EEF1A2 and ovarian carcinoma: We have previously demonstrated that conjugation to a toxin confers target-specific in vitro cytotoxicity to a murine anti-STn antibody[30], and have confirmed those findings utilizing the ovarian cancer cell line, SKOV3, engineered to overexpress STn.